ARS Pharmaceuticals, Inc. (SPRY) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$171.30M | -2241.8% |
| 2024 | $8.00M | +114.7% |
| 2023 | -$54.37M | -56.8% |
| 2022 | -$34.68M | -71.3% |
| 2021 | -$20.24M | +38.6% |
| 2020 | -$32.95M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$171.30M | -2241.8% |
| 2024 | $8.00M | +114.7% |
| 2023 | -$54.37M | -56.8% |
| 2022 | -$34.68M | -71.3% |
| 2021 | -$20.24M | +38.6% |
| 2020 | -$32.95M | — |